1. Home
  2. NTHI vs LARK Comparison

NTHI vs LARK Comparison

Compare NTHI & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • LARK
  • Stock Information
  • Founded
  • NTHI 2008
  • LARK 1885
  • Country
  • NTHI United States
  • LARK United States
  • Employees
  • NTHI N/A
  • LARK N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • LARK Major Banks
  • Sector
  • NTHI Health Care
  • LARK Finance
  • Exchange
  • NTHI Nasdaq
  • LARK Nasdaq
  • Market Cap
  • NTHI 155.4M
  • LARK 142.3M
  • IPO Year
  • NTHI N/A
  • LARK N/A
  • Fundamental
  • Price
  • NTHI $11.00
  • LARK $27.25
  • Analyst Decision
  • NTHI
  • LARK
  • Analyst Count
  • NTHI 0
  • LARK 0
  • Target Price
  • NTHI N/A
  • LARK N/A
  • AVG Volume (30 Days)
  • NTHI 87.3K
  • LARK 5.8K
  • Earning Date
  • NTHI 08-19-2025
  • LARK 10-29-2025
  • Dividend Yield
  • NTHI N/A
  • LARK 3.10%
  • EPS Growth
  • NTHI N/A
  • LARK 42.91
  • EPS
  • NTHI N/A
  • LARK 2.81
  • Revenue
  • NTHI $59,990.00
  • LARK $62,413,000.00
  • Revenue This Year
  • NTHI N/A
  • LARK N/A
  • Revenue Next Year
  • NTHI N/A
  • LARK N/A
  • P/E Ratio
  • NTHI N/A
  • LARK $9.69
  • Revenue Growth
  • NTHI N/A
  • LARK 11.63
  • 52 Week Low
  • NTHI $3.20
  • LARK $18.81
  • 52 Week High
  • NTHI $25.00
  • LARK $31.04
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • LARK 57.91
  • Support Level
  • NTHI N/A
  • LARK $26.55
  • Resistance Level
  • NTHI N/A
  • LARK $27.24
  • Average True Range (ATR)
  • NTHI 0.00
  • LARK 0.36
  • MACD
  • NTHI 0.00
  • LARK 0.02
  • Stochastic Oscillator
  • NTHI 0.00
  • LARK 81.33

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

Share on Social Networks: